Abstract
Abstract
Four-Dimensional Computed Tomography (4D CT) is of increasing importance in stereotactic body radiotherapy (SBRT) treatments affected by respiratory motion. However, 4D CT images are commonly impacted by irregular breathing, causing image artifacts that can propagate through to treatment, negatively effecting local control. REspiratory Adaptive CT (REACT) is a real-time gating method demonstrated to reduce motion artifacts by avoiding imaging during irregular respiration. Despite artifact reduction seen through in silico and clinical phantom-based studies, REACT has not been able to remove all artifacts. Here, we explore several hardware and software latencies (gantry rotation time, couch shifts, acquisition delays and phase calculation method) inherently linked to REACT and 4D CT in general and investigate their contribution to artifacts beyond those caused by irregular breathing. Imaging was simulated using the digital extended cardiac-torso (XCAT) phantom for fifty patient-measured respiratory traces. Imaging protocols included conventional cine 4D CT and five REACT scans with systematically varied parameters to test the effect of different latencies on artifacts. Artifacts were quantified by comparing the image normalized cross correlation across couch transition points and determining the volume error compared to a static phantom ground truth both as a total error and individually across pixel rows in the main plane of motion. Artifacts were determined for each lung, the whole heart and lung tumour and were compared back to conventional 4D CT and REACT with standard clinical scanning parameters. The gantry rotation time and acquisition delay were found to have the largest impact on reducing image artifacts and should be the focus of future development. The phase calculation method was also found to influence motion artifacts and should potentially be assessed on a patient-to-patient basis. Finally, the correlation between an increase in artifacts and baseline drift suggests that longer scan times allowing drift to occur may impact image quality.
Funder
National Health and Medical Research Council
Cancer Australia: Priority Driven Collaborative Cancer Research Scheme